Company intelligence / Profile preview

HemoAssay Science

Providence, Rhode Island, United States

Ownership: Private
Development stage: Other

Overview

HemoAssay is a specialized contract research organization (CRO) that provides advanced hemocompatibility testing services for the medical device and pharmaceutical industries. The company utilizes proprietary microfluidic technology to simulate physiological blood flow conditions, allowing for more accurate assessment of blood-device interactions such as thrombosis and hemolysis. By offering high-throughput and clinically relevant assays, HemoAssay helps developers optimize device design and meet regulatory requirements for blood-contacting products. Their services are particularly critical for the development of stents, catheters, heart valves, and other cardiovascular interventions.

Therapeutic areas: HematologyCardiovascular
Modalities: Device
Industry: Contract Research Organization

Beyond the preview

Go deeper on HemoAssay Science.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on HemoAssay Science.

Explore the full profile